Skip to main content
RPRX
NASDAQ Life Sciences

Royalty Pharma Commits $500M to J&J Autoimmune Drug Development

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$46.94
Mkt Cap
$26.74B
52W Low
$29.66
52W High
$47.86
52W Position info
58% above low
Off High info
1.9% below high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

RPRX sits 58% above its 52-week low of $29.66.

Summary

Royalty Pharma announced a significant R&D co-funding agreement with Johnson & Johnson, committing $500 million over 2026 and 2027 to advance JNJ-4804, a novel co-antibody therapy for chronic immune-mediated diseases. This strategic collaboration is a material investment for Royalty Pharma, directly supporting its business model of funding promising biopharmaceutical assets in exchange for future royalty streams. Partnering with a recognized leader like Johnson & Johnson on a potentially high-impact immunology drug is a positive development that could enhance Royalty Pharma's long-term portfolio value and future revenue generation. Traders will monitor the clinical progress of JNJ-4804 as a key future catalyst for Royalty Pharma.

At the time of this announcement, RPRX was trading at $46.94 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $26.7B. The 52-week trading range was $29.66 to $47.86. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

RPRX - Latest Insights

RPRX
Nov 04, 2026, 9:03 AM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $66.20
Real-time Price: $67.91 info
Change: +$1.71 (+3%) info
Market Cap: $39.267B info
RPRX
Nov 04, 2026, 7:38 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $66.40
Real-time Price: $67.91 info
Change: +$1.51 (+2%) info
Market Cap: $39.267B info
RPRX
Nov 04, 2026, 7:00 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $66.58
Real-time Price: $67.91 info
Change: +$1.33 (+2%) info
Market Cap: $39.267B info
RPRX
Aug 12, 2026, 5:23 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $59.22
Real-time Price: $67.91 info
Change: +$8.69 (+15%) info
Market Cap: $39.267B info
RPRX
Aug 05, 2026, 9:02 AM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $57.69
Real-time Price: $67.91 info
Change: +$10.22 (+18%) info
Market Cap: $39.267B info